medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2021-5-14-17medalphabet-1956Research ArticleСтатьиКардиологические осложнения у пациентов с тяжелым течением пневмонии COVID-19Cardiac complications in patients with severe COVID-19 pneumoniaЯрощукН. А.YaroshchukN. А.

 Наталия Андреевна Ярощук - к. м. н., заведующая отделением функциональной и ультразвуковой диагностики

Тел. +7 (343) 376-96-62

 MD, PhD, Head of the Department of Functional and Ultrasound Diagnostics

КочмашеваВ. В.KochmashevaV. V.

д. м. н., профессор кафедры, заведующая отделением функциональной и ультразвуковой диагностики

 MD, Professor at the Department, Head of the Department of Functional Diagnostics

ВахрамеевА. В.VakhrameevA. V.

врач-кардиолог

cardiologist

ГАУЗ СО «СОКП госпиталь для ветеранов войн», г. ЕкатеринбургРоссияGAUZ SO ‘Sverdlovsk Regional Clinical Neuropsychiatric hospital for war veterans’, YekaterinburgRussian FederationФГБОУ «Уральский государственный медицинский университет», ГАУЗ СО «Свердловская областная клиническая больница № 1», г. ЕкатеринбургРоссияFGBOU ‘Ural State Medical University”, GAUZ SO “Sverdlovsk Regional Clinical Hospital No. 1’, YekaterinburgRussian Federation20211204202105Современная функциональная диагностика (1)1417Copyright © Ярощук Н.А., Кочмашева В.В., Вахрамеев А.В., 20212021Ярощук Н.А., Кочмашева В.В., Вахрамеев А.В.Yaroshchuk N.А., Kochmasheva V.V., Vakhrameev A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/1956

Данная статья посвящена анализу наиболее частых кардиологических осложнений у пациентов с тяжелым течением внебольничной пневмонии, вызванной вирусной инфекцией СOVID-19. В ходе исследования выявлено, что кардиологические осложнения развились у 25 % пациентов с пневмонией COVID-19. Наиболее частым осложнением были суправентрикулярные нарушения ритма. Фибрилляция и трепетание предсердий протекали с выраженными гемодинамическими изменениями. Повреждение миокарда, учитывая повышение кардиоспецифического тропонина Т, можно было заподозрить у 38 % пациентов. Наибольшие затруднения вызвали дифференциальный диагноз между ОКС и миокардитом.

This article is devoted to the analysis of the most frequent cardiac complications in patients with severe community-acquired pneumonia caused by COVID-19 viral infection. The study found that cardiac complications developed in 25% of patients with COVID-19 pneumonia. The most common complication was supraventricular rhythm disturbances. Atrial fibrillation and flutter proceeded with pronounced hemodynamic changes. Myocardial injury, given the increase in cardiospecific troponin T, could be suspected in 38% of patients. Differential diagnosis between ACS and myocarditis caused the greatest difficulties.

внебольничная пневмония COVID-19кардиологические осложненияповреждение миокардамиокардитcommunity-acquired pneumonia COVID-19cardiac complicationsmyocardial injurymyocarditisReferencesAkhmerov A., Marbán Е. COVID-19 and the heart. Circulation research. 2020;126(10):1443–1455.Akhmerov A., Marbán Е. COVID-19 and the heart. Circulation research. 2020;126(10):1443–1455.Rath D., Petersen- Uribe Á., Avdiu A., Witzel K., Jaeger P., Zdanyte M., Gawaz M. P. Impaired cardiac function is associated with mortality in patients with acute COVID-19 infection. Clinical Research in Cardiology. 2020; 1–9.Rath D., Petersen- Uribe Á., Avdiu A., Witzel K., Jaeger P., Zdanyte M., Gawaz M. P. Impaired cardiac function is associated with mortality in patients with acute COVID-19 infection. Clinical Research in Cardiology. 2020; 1–9.Ruan Q., Yang K., Wang W., Jiang L., Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive care medicine. 2020;46(5):846–848.Ruan Q., Yang K., Wang W., Jiang L., Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive care medicine. 2020;46(5):846–848.Алёхин М. Н., Иванов С. И., Степанова А. И. Клиническое значение эхокардиографии у больных с COVID-19: систематический обзор. Медицинский алфавит. 2020;(32):8–13. https://doi.org/10.33667/2078-5631-2020-32-8-13Alekhin M. N., Ivanov S. I., Stepanova A. I. Clinical value of echocardiography in patients with COVID-19: a systematic review. Medicalalphabet. 2020;(32):8–13. https://doi.org/10.33667/2078-5631-2020-32-8-13Bansal M. Cardiovascular disease and COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(3):247–250.Bansal M. Cardiovascular disease and COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(3):247–250.Liu P. P., Blet A., Smyth D., Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020;142:68–78 https://doi.org/10.1161/CIRCULATIONAHA.120.047549Liu P. P., Blet A., Smyth D., Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020;142:68–78 https://doi.org/10.1161/CIRCULATIONAHA.120.047549Long B., Brady W. J., Koyfman A., Gottlieb M. Cardiovascular complications in COVID-19. The American journal of emergency medicine. 2020; 38,(7):1504–1507 https://doi.org/10.1016/j.ajem.2020.04.048Long B., Brady W. J., Koyfman A., Gottlieb M. Cardiovascular complications in COVID-19. The American journal of emergency medicine. 2020; 38,(7):1504–1507 https://doi.org/10.1016/j.ajem.2020.04.048Basso C. et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study //European heart journal. — 2020. — Т. 41. — № 39. —С. 3827–3835.Basso C. et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study //European heart journal. — 2020. — Т. 41. — № 39. —С. 3827–3835.Nishiga M., Wang D. W., Han Y., Lewis D. B., W, J. C. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nature Reviews Cardiology.2020;17(9):543–558.Nishiga M., Wang D. W., Han Y., Lewis D. B., W, J. C. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nature Reviews Cardiology.2020;17(9):543–558.Januzzi J. L. Troponin and BNP use in COVID-19. Cardiology Magazine. 2020;18.Januzzi J. L. Troponin and BNP use in COVID-19. Cardiology Magazine. 2020;18.Lippi G., Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clinical Chemistry and Laboratory Medicine. 2020;58(7):1131–1134.Lippi G., Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clinical Chemistry and Laboratory Medicine. 2020;58(7):1131–1134.Sandoval Y., Januzzi Jr J. L., Jaffe A. S. Cardiac troponin for the diagnosis and risk-stratification of myocardial injury in COVID-19: JACC review topic of the week. Journal of the American College of Сardiology. 2020;76(10.8):1244–1258.Sandoval Y., Januzzi Jr J. L., Jaffe A. S. Cardiac troponin for the diagnosis and risk-stratification of myocardial injury in COVID-19: JACC review topic of the week. Journal of the American College of Сardiology. 2020;76(10.8):1244–1258.Guo T. Fan Y., Chen M., Wu X., Zhang L., He T., Lu Z. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA cardiology. 2020; 5(7):811–818.Guo T. Fan Y., Chen M., Wu X., Zhang L., He T., Lu Z. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA cardiology. 2020; 5(7):811–818.Haseeb S., Gul E. E., Çinier G., Bazoukis G., AlvarezGarcia J., Garcia- Zamora S., Baranchuk A. Value of electrocardiography in coronavirus disease 2019 (COVID-19). Journal of Electrocardiology. 2020;62:39–45.Haseeb S., Gul E. E., Çinier G., Bazoukis G., AlvarezGarcia J., Garcia- Zamora S., Baranchuk A. Value of electrocardiography in coronavirus disease 2019 (COVID-19). Journal of Electrocardiology. 2020;62:39–45.Kochi A. N., Tagliari, A.P., Forleo G. B., Fassini G. M., Tondo C.l. Cardiac and arrhythmic complications in patients with COVID-19. Journal of Cardiovascular Electrophysiology. 2020;31(5):1003–1008.Kochi A. N., Tagliari, A.P., Forleo G. B., Fassini G. M., Tondo C.l. Cardiac and arrhythmic complications in patients with COVID-19. Journal of Cardiovascular Electrophysiology. 2020;31(5):1003–1008.Lazzerini P. E., Boutjdir M., Capecchi P. L. COVID-19, arrhythmic risk and inflammation: mind the gap! Circulation. 2020;142:7–9.Lazzerini P. E., Boutjdir M., Capecchi P. L. COVID-19, arrhythmic risk and inflammation: mind the gap! Circulation. 2020;142:7–9.Bennett C. E., Anavekar N. S., Gulati R., Singh M., Kane G. C., Sandoval Y., Aske J. W. ST-segment elevation, myocardial injury, and suspected or confirmed COVID-19 patients: diagnostic and treatment uncertainties. Mayo Clinic Proceedings. Elsevier. 2020; 95(6):1107–1111.Bennett C. E., Anavekar N. S., Gulati R., Singh M., Kane G. C., Sandoval Y., Aske J. W. ST-segment elevation, myocardial injury, and suspected or confirmed COVID-19 patients: diagnostic and treatment uncertainties. Mayo Clinic Proceedings. Elsevier. 2020; 95(6):1107–1111.Chen Q. Xu L., Dai Y., Ling Y., Mao J., Qian J., Ge J. Cardiovascular manifestations in severe and critical patients with COVID-19. Clinical cardiology. 2020;43(7):796–802.Chen Q. Xu L., Dai Y., Ling Y., Mao J., Qian J., Ge J. Cardiovascular manifestations in severe and critical patients with COVID-19. Clinical cardiology. 2020;43(7):796–802.Ni W., Yang X., Liu J., Bao J., Li R., Xu Y., Gao Z. Acute myocardial injury at hospital admission is associated with all-cause mortality in COVID-19. Journal of the American College of Cardiology. 2020;76(1):124–125.Ni W., Yang X., Liu J., Bao J., Li R., Xu Y., Gao Z. Acute myocardial injury at hospital admission is associated with all-cause mortality in COVID-19. Journal of the American College of Cardiology. 2020;76(1):124–125.Wang, Dawei, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.Wang, Dawei, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.Mitrani R. D., Dabas N., Goldberger J. J. COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors.Heart rhythm. 2020;17(11):1984–1990.Mitrani R. D., Dabas N., Goldberger J. J. COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors.Heart rhythm. 2020;17(11):1984–1990.Bu J., Chen M., Cheng X., Dong Y., Fang W., Ge J. Consensus of Chinese experts on diagnosis and treatment processes of acute myocardial infarction in the context of prevention and control of COVID-19. Nan Fang Yi Ke Da Xue Xue Bao. 2020;147–151.Bu J., Chen M., Cheng X., Dong Y., Fang W., Ge J. Consensus of Chinese experts on diagnosis and treatment processes of acute myocardial infarction in the context of prevention and control of COVID-19. Nan Fang Yi Ke Da Xue Xue Bao. 2020;147–151.Mahmud E., Dauerman H. L., Welt F. G., Messenger J. C., Rao S. V., Grines C., Rokos I. C. Management of acute myocardial infarction during the COVID-19 pandemic. Journal of the American College of Cardiology. 2020;76(11):1375–1384.Mahmud E., Dauerman H. L., Welt F. G., Messenger J. C., Rao S. V., Grines C., Rokos I. C. Management of acute myocardial infarction during the COVID-19 pandemic. Journal of the American College of Cardiology. 2020;76(11):1375–1384.Гриневич В. Б., Губонина И. В., Дощицин В. Л., Котовская Ю. В., Кравчук Ю. А., Педь В. И., Ткачёва О. Н. Особенности ведения коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19). Национальный Консенсус 2020. Кардиоваскулярная терапия и про-филактика. 2020;19(4): https://doi.org/10.15829/1728-8800-2020-2630.Grinevich V. B., Gubonina I. V., Doshchitsin V. L., Kotovskaya Yu. V., Kravchuk Yu. A., Ped ‘V. I., Tkacheva O. N. Features of the management of comorbid patients during the novel coronavirus pandemic infections (COVID-19). National Consensus 2020. Cardiovascular Therapy and Prevention. 2020;19(4): https://doi.org/10.15829/1728-8800-2020-2630.Шляхто Е. В. Конради А. О., Арутюнов Г. П., Арутюнов А. Г., Баутин А. Е., Бойцов С. А., Козиолова Н. А. Руководство по диагностике и лечению болезней системы кровообращения в контексте пандемии COVID-19. Российский кардиологический журнал. 2020;25(3):1–20.Shlyakhto E. V., Konradi A. O., Arutyunov G. P., Arutyunov A. G., Bautin A. E., Boytsov S. A., Koziolova N. A. Guide to the diagnosis and treatment of diseases of the circulatory system in the context pandemic COVID-19. Russian journal of cardiology. 2020;25(3):1–20.Bangalore S., Sharma A., Slotwiner A., Yatskar L., Harari R., Shah B., Chadow H. L. ST-segment elevation in patients with Covid-19 — a case series. New England Journal of Medicine. 2020; doi: 10.1056/NEJMc2009020Bangalore S., Sharma A., Slotwiner A., Yatskar L., Harari R., Shah B., Chadow H. L. ST-segment elevation in patients with Covid-19 — a case series. New England Journal of Medicine. 2020; doi: 10.1056/NEJMc2009020Knight D. S., Kotecha T., Razvi Y., Chacko L., Brown, J.T., Jeetley P. S., Wolff A. COVID-19: Myocardial injury in survivors. Circulation. 2020;142 (11):1120–1122.Knight D. S., Kotecha T., Razvi Y., Chacko L., Brown, J.T., Jeetley P. S., Wolff A. COVID-19: Myocardial injury in survivors. Circulation. 2020;142 (11):1120–1122.Головкин А. С., Кудрявцев И. В., Дмитриев А. В., Калинина О. В. Фиброзные изменения сердечно-сосудистой и дыхательной систем после пере-несенной COVID-19: вклад факторов иммунной системы и генетическая предрасположенность. Российский кардиологический журнал. 2020;25(10):214–220.Golovkin A. S., Kudryavtsev I. V., Dmitriev A. V., Kalinina O. V. Fibrous changes in the cardiovascular and respiratory systems after suffering from COVID-19: the contribution of immune system factors and genetic predisposition. Russian journal of cardiology. 2020;25(10):214–220.Siripanthong B. Nazarian S., Muser D., Deo R., Santangeli P., Khanji M. Y., Chahal C. A. A. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17(9):1463–1471.Siripanthong B. Nazarian S., Muser D., Deo R., Santangeli P., Khanji M. Y., Chahal C. A. A. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17(9):1463–1471.Xu H., Hou K., Xu H., Li Z., Chen H., Zhang N., Xie L. Acute Myocardial Injury of Patients with Coronavirus Disease 2019. MedRxiv. 2020; https://doi.org/10.1101/2020.04.17.20064691Xu H., Hou K., Xu H., Li Z., Chen H., Zhang N., Xie L. Acute Myocardial Injury of Patients with Coronavirus Disease 2019. MedRxiv. 2020; https://doi.org/10.1101/2020.04.17.20064691Yancy C. W., Fonarow G. C. Coronavirus disease 2019 (COVID-19) and the heart — Is heart failure the next chapter? JAMA cardiology. 2020;5(11):1216–1217Yancy C. W., Fonarow G. C. Coronavirus disease 2019 (COVID-19) and the heart — Is heart failure the next chapter? JAMA cardiology. 2020;5(11):1216–1217

The authors declare that there are no conflicts of interest present.